Health Care and Life Settlement Ponzi Schemes: Investors Paid. Who Got the Money?

In health care and life settlement Ponzi schemes, new investment money sustains payments that investors believe their investments earned. The underlying pitch may concern policy interests, receivables or a healthcare business. If you handle the accounts, sell the investment or reconcile its payments, you may know where the money actually came from and what investors were told about it.

These cases put the investment promise beside the destination of the money. Our broader comparison of Ponzi cases across different businesses follows the same question across other industries. This page follows the policy interests sold, the receivables supposedly bought and the payments that reached earlier investors.

What Qualifies as a Health Care or Life Settlement Ponzi Scheme?

A Ponzi scheme pays earlier investors with money from later investors while misrepresenting where those payments came from. The connection runs from the sales promise through incoming investment money to outgoing principal or supposed earnings. An investor sees a payment arrive. An employee handling the transfer may see the new deposit that made it possible.

The SEC’s account of GCA gives that comparison concrete meaning. In its June 2013 allegations, the agency said GCA raised nearly $10 million and returned about $2 million to investors as Ponzi payments. In the SEC’s account, those payments helped sustain the deception. We call that buying the appearance of success with the investors’ own money.

MRI International and the Source of Earlier Payments

The SEC’s complaint against MRI International alleged that approximately $601 million of new and reinvested investor money paid existing investors’ claims for principal or interest between January 2009 and March 2013. The promised principal and interest came from the next round of investment money.

For an insider reconciling investor accounts, the useful comparison joins the offering documents, the accounting entry and the recipient of the transfer. An investor ledger can show a balance, an interest entry and a payment without explaining the source of the money. The bank transfer supplies another part of the story, and the offering documents explain what the investor was promised. Someone who knows how those entries were recorded can help connect the payment to its actual funding.

Mutual Benefits, Christian Stanley and Life Settlement Interests

Mutual Benefits sold fractional interests in viatical and life settlements, according to the SEC’s May 2004 account of its complaint. The agency alleged that the offering raised over $1 billion from more than 29,000 investors. It also alleged that investors were not told that at least $26 million of the proceeds went to individuals behind the offering and their relatives as consulting fees.

That allegation gives an employee a specific comparison to recognize: what purchasers were told their money would finance, what the books called the payment and who received it. The fee description is part of the evidence, alongside the disclosure investors received. In the SEC’s allegation, investors paid for policy interests while undisclosed recipients took a cut.

The SEC also brought a case against Christian Stanley, a Los Angeles company that purported to broker life settlements. Its September 2011 announcement described an emergency court order halting an alleged life settlement investment scheme.

Medical Capital’s Receivables and Administrative Fees

Medical Capital’s offering documents described how investor money was being used to purchase accounts receivable. In its August 2009 complaint announcement, the SEC alleged that approximately $18.5 million of the $76.9 million raised through MP VI notes was misappropriated to pay administrative fees. The agency said those payments contradicted supplemental offering documents representing that less than $4 million had gone to purposes other than buying receivables. In the SEC’s allegation, the fees shrank in the disclosure.

The SEC also alleged that investors were falsely told no prior offerings had defaulted or been late paying principal or interest. Yet its complaint described five of its funding companies in default or late paying principal or interest on $992.5 million in notes, with missed payments dating from August 2008. Someone maintaining investor accounts may know about missed payments that the next offering’s disclosures leave out. An insider who reviewed those disclosures or processed the fees can explain how the numbers reached investors.

This is where receivables investments meet the ordinary accounting trail. Investor subscriptions supply money to an offering. Business receipts, expenses and investor distributions are separate movements. Comparing the promised use with the bank destination makes the distinction concrete. In Medical Capital, the SEC’s allegation puts the fee payments directly against the representation about receivables purchases.

When the Person Paying Is a Patient

A healthcare pitch can also seek money directly from patients under a promise that it will come back. A criminal information against a wellness-business founder alleged that the founder told patients Vanderbilt required an upfront payment of $10,000 to join a study and that their money would be returned after one year, as the Justice Department’s October 2020 announcement described. In that alleged pitch, patients were being asked to part with their money on the strength of a university’s name. An insider who handled the payment requests could connect the claimed study to the promise of repayment.

What an Insider Can Explain About the Money

The useful securities fraud evidence connects the representation, the transaction and the people who authorized it. Subscription records show incoming investment money. Offering documents describe its promised use. Ledgers, bank destinations and payment instructions show what the business did with it. Your knowledge can connect entries that look unrelated to someone outside the company.

A study of occupational fraud, The Significance of Whistleblowing as an Anti-Fraud Measure, published in the Journal of Forensic & Investigative Accounting in 2018, found that whistleblowing became more likely to be the detection method as more people participated in a scheme. That finding helps explain why we want to hear from the person who knows one part of the transaction: the sales representation, the fee approval or the transfer. A particular payment and the explanation given for it are a concrete place to begin a conversation with us.

Whistleblower Rewards for Investment Fraud

The SEC whistleblower program can reward information about securities fraud. Its award announcement describes awards of 10 percent to 30 percent of the money collected when monetary sanctions exceed $1 million. Your knowledge of an offering’s promises and payments is the starting point for our assessment of a possible securities fraud whistleblower case.

Where the conduct concerns fraudulent claims to the government, a whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. We work through which whistleblower program fits the facts with you, including how the investment transactions connect to any government payments.

You Know What the Payment Was For

If you know why money described as policy investment, receivables funding or earnings went somewhere else, speak with our whistleblower experts about the payments. We build a case strategy around your knowledge and bring in securities fraud whistleblower lawyers who understand investment offerings and the accounting behind them. We stay with you through the case, pressing the connection between what investors were promised and where their money went.